| 1981 |
Entactin (NID1) is a sulfated glycoprotein of approximately 158 kDa isolated from extracellular basement membrane-like matrix; it is immunologically and biochemically distinct from laminin (GP-2) and fibronectin, and localizes predominantly at epithelial cell surfaces adjacent to basement membranes in mouse and rat kidney. |
Protein isolation, antibody preparation, immunoelectron microscopy, SDS-PAGE, cyanogen bromide peptide fragmentation, H235SO4 incorporation, chondroitinase ABC treatment |
The Journal of biological chemistry |
High |
6262321
|
| 1988 |
The complete amino acid sequence of mouse entactin predicts a 1,245-residue polypeptide organized into three structural domains: an N-terminal globular domain (~70 kDa), a cysteine-rich stalk (~28 kDa) containing six EGF-type repeats and one thyroglobulin-type repeat, and a C-terminal globular domain (~36 kDa) with homology to EGF precursor and LDL receptor. Two potential Ca2+-binding sites are present. An RGD cell-recognition sequence is located in one EGF-type repeat and a synthetic RGD-containing peptide promotes mammary tumor cell attachment. |
cDNA cloning and sequencing, sequence analysis, synthetic peptide cell attachment assay |
The Journal of cell biology |
High |
3264556
|
| 1990 |
Entactin promotes cell attachment of mouse mammary tumor, human melanoma, and other cells; the RGD sequence in entactin mediates approximately 60% of this attachment (inhibited by RGDS peptide), indicating additional non-RGD cell recognition sequences exist. Entactin directly binds calcium ions, with binding sites residing in the NH2-terminal region (demonstrated by recombinant N-terminal 330 aa fragment and synthetic calcium-binding peptides). |
Cell attachment assay, peptide inhibition assay, baculovirus-expressed recombinant entactin, 45Ca2+ binding assay, synthetic peptides |
The Journal of biological chemistry |
High |
2191952
|
| 1990 |
Entactin's C-terminal globular domain binds tightly to the inner rod-like segment of laminin's short arms, and the same region mediates attachment to type IV collagen approximately 80 nm from its carboxyl non-collagenous end. Transfection of entactin cDNA into JAR choriocarcinoma cells (which lack entactin) stimulated incorporation of laminin and type IV collagen into extracellular matrix, demonstrating entactin's bridging role in basement membrane assembly. |
Transfection assay, immunofluorescence, binding studies, domain analysis |
American journal of respiratory cell and molecular biology |
Medium |
2119632
|
| 1990 |
Recombinant entactin expressed in a baculovirus system is correctly processed (signal peptide cleaved), promotes cell attachment, and exhibits calcium- and temperature-dependent self-aggregation. Immunoelectron microscopy showed the majority of recombinant entactin localizes intracellularly forming insoluble aggregates in insect cells. |
Baculovirus expression system, amino terminus sequence analysis, cell attachment assay, calcium/temperature-dependent aggregation assay, immunoelectron microscopy |
The Journal of biological chemistry |
Medium |
2180961
|
| 1991 |
Entactin specifically binds to the Aα and Bβ chains of fibrinogen in a divalent cation-independent, saturable, and concentration-dependent manner. Entactin can be cross-linked to itself and to fibrin(ogen) by transglutaminase. |
Solid phase binding assay with 35S-labeled entactin, competitive inhibition with antibodies and unlabeled ligands, transglutaminase cross-linking assay |
The Journal of biological chemistry |
High |
1680863
|
| 1992 |
The cell surface receptor for entactin on PC-3 prostate carcinoma cells is integrin α3β1. The receptor was isolated by affinity chromatography on entactin-Sepharose, bound in a divalent cation-dependent manner (Ca2+, Mg2+, Mn2+), was eluted with EDTA but not RGD-containing peptides, and anti-α3 antibody (P1B5) inhibited cell attachment to entactin but not to laminin. |
Affinity chromatography on entactin-Sepharose, 125I surface labeling, anti-integrin antibody identification, purified α3β1 binding assay, liposome reconstitution, antibody inhibition of cell attachment |
The Journal of biological chemistry |
High |
1527019
|
| 1992 |
Entactin mediates neutrophil (PMN) adhesion and chemotaxis through its RGD domain via the leukocyte response integrin (LRI). An RGD-containing synthetic peptide (S-RGD) reproduced the effect; a mutant entactin with RGE substitution at Asp674 had no adhesive or chemotactic activity. Anti-LRI monoclonal antibodies blocked both adhesion and chemotaxis, while anti-β1 and anti-β2 integrin antibodies had no effect. |
Cell adhesion assay, chemotaxis assay, synthetic peptide competition, site-directed mutant recombinant entactin (RGD→RGE), monoclonal antibody blocking, HL-60 differentiation model |
The Journal of clinical investigation |
High |
1469085
|
| 1993 |
Entactin is a substrate for matrix metalloproteinases, with matrilysin being ~100-fold more effective than interstitial collagenase and ~600-fold more effective than 92-kDa gelatinase. The Km of matrilysin for entactin is 8.9×10−7 M and Vmax is 21 molecules/enzyme/min at 37°C. Cleavage sites consistently occur amino-terminal to leucine or isoleucine residues. |
In vitro MMP cleavage assay, kinetic analysis (Km, Vmax, Arrhenius plot), Edman degradation of cleavage fragments |
The Journal of biological chemistry |
High |
8380588
|
| 1993 |
Entactin binds to laminin, collagen IV, fibrinogen, fibronectin, and is assembled into complex with laminin intracellularly in parietal endoderm M1536-B3 cells, then transported in membrane-enclosed vesicles to the extracellular compartment. Transfection of entactin into JAR cells (lacking entactin) results in entactin incorporation into extracellular matrix associated with laminin and collagen IV. Entactin also co-localizes with fibronectin in 4CQ cell extracellular matrix. |
Cell fractionation, immunofluorescence, cDNA transfection, indirect immunostaining |
Kidney international |
Medium |
8433553
|
| 1993 |
Recombinant entactin promotes mouse primary trophoblast cell adhesion and migration (blastocyst outgrowth) in a dose-dependent manner via its RGD recognition site. A mutant recombinant entactin with Glu substituted for Asp at the RGD site provided no trophoblast adhesive activity, and RGD-containing peptide reversibly inhibited entactin-mediated outgrowth. |
Blastocyst outgrowth assay, site-directed mutagenesis (RGD→RGE), antibody inhibition, peptide competition assay |
The Journal of cell biology |
High |
8491783
|
| 1994 |
The 29 kDa amino-terminal fragment of fibronectin binds specifically to the G2 domain of entactin (half-saturation ~5 nM), but not to G1, E, or G3 domains, identifying G2 as the fibronectin-binding domain of entactin. |
GST-fusion protein domain analysis, solid phase binding assay with 125I-labeled fibronectin fragment |
Biochemical and biophysical research communications |
Medium |
8147897
|
| 1994 |
Entactin binds specifically to Candida albicans cell wall components in both yeast and hyphal forms; binding is partially inhibited by RGDS peptide and completely abolished by anti-entactin antiserum. Cell wall proteins of ~25, 44, and 65 kDa from both morphologies bind entactin in ligand affinity blotting. |
Indirect immunofluorescence, ELISA binding assay, ligand affinity blotting, RGDS peptide competition |
Infection and immunity |
Medium |
7927722
|
| 1995 |
Entactin has two distinct cell attachment sites: (1) the RGD sequence in the EGF-like stalk (E domain), recognized by αvβ3 integrin; and (2) a 39-amino acid cysteine-rich EGF repeat in the G2 domain, which serves as a second attachment site recognized by a β1 family integrin (possibly α3β1), independent of RGD. |
GST-fusion protein domain constructs, RGD deletion and Glu-for-Asp substitution mutagenesis, full-length mutant entactin in baculovirus system, cell attachment assay, anti-integrin antibody inhibition |
The Journal of biological chemistry |
High |
7797588
|
| 1996 |
Entactin E domain (containing RGD) ligates the leukocyte response integrin (beta3-like) and signals for neutrophil chemotaxis, while the G2 domain signals for enhancement of Fc receptor-mediated phagocytosis via ligation of α3β1. These are distinct receptor-domain interactions mediating different neutrophil functions. Matrilysin cleavage of entactin liberates peptides retaining both E domain-mediated chemotaxis and G2 domain-mediated phagocytosis enhancement. |
GST-domain fusion proteins (G1, G2, E, G3), neutrophil chemotaxis assay, phagocytosis assay, anti-integrin antibody blocking, matrilysin cleavage |
The Journal of biological chemistry |
High |
8940031
|
| 1996 |
Stromelysin-1 (MMP-3) specifically cleaves entactin in the mammary gland extracellular matrix in vivo; enhanced entactin cleavage to above-normal levels was directly correlated with apoptosis of overlying mammary epithelial cells. TIMP-1 overexpression suppressed MMP activity, prevented entactin degradation, and extinguished the apoptosis. |
Transgenic mouse crosses (stromelysin-1 autoactivating transgene × TIMP-1 transgene), in vivo genetic epistasis, quantification of entactin cleavage products, apoptosis assay |
The Journal of cell biology |
High |
8978831
|
| 1991 |
Entactin forms a complex with fibronectin and co-localizes in extracellular matrix of the 4CQ embryonal carcinoma cell line, which lacks laminin. The entactin-fibronectin interaction was confirmed by affinity column chromatography and solid phase assay, demonstrating direct binding. |
Immunofluorescence co-localization, affinity column chromatography, solid phase binding assay, Northern blot |
Biochemical and biophysical research communications |
Medium |
1872841
|
| 1988 |
Tyrosine sulfation of entactin occurs in medial Golgi cisternae (not trans-Golgi), and is not the last modification before secretion. Four intracellular precursor forms of entactin (EN1–4) at different modification stages were identified; the mature secreted form is tyrosine-sulfated. |
Metabolic labeling with [35S]methionine and H235SO4, tunicamycin and monensin inhibitor experiments, pulse-chase analysis in 3T3-L1 adipocytes |
FEBS letters |
Medium |
3042455
|
| 2002 |
Targeted disruption of the entactin-1 (nidogen-1) gene in mice causes neurological deficits (seizure-like symptoms, loss of hindleg muscle control) and selective structural alterations in basement membranes at brain capillaries and lens capsule, while basement membranes in most other tissues appeared morphologically normal. |
Gene targeting/knockout mouse, behavioral observation, immunohistochemistry, electron microscopy of basement membranes |
Laboratory investigation |
High |
12480912
|
| 2003 |
In entactin-1-null mice, glomerular basement membranes show thickening, altered anionic charge distribution, and increased αv-integrin density at glomerular cell membranes compared to wild type. Filtration permselectivity is altered (endogenous albumin distribution across basement membrane is changed). Laminin and type IV collagen distributions remain unchanged. |
Immunocytochemistry, protein A-gold quantitative electron microscopy, albumin distribution assay in knockout vs. wild-type mice |
The journal of histochemistry and cytochemistry |
High |
14566019
|
| 1992 |
Entactin is required for long-term adhesion and maintenance of contractile skeletal myotubes on diluted Matrigel. Anti-entactin antibodies did not inhibit myoblast attachment or fusion, but myotubes exposed to anti-entactin detached after spontaneous contractions began, identifying a specific role for entactin in post-fusion myotube stabilization. |
Antibody blocking with anti-entactin, anti-laminin, anti-collagen IV, anti-HSPG; myotube culture on Matrigel; contractility observation |
Journal of cellular physiology |
Medium |
1734030
|
| 1994 |
A novel entactin epitope (recognized by monoclonal antibody 9H6) is selectively present at the synaptic cleft of the neuromuscular junction but not at extrasynaptic sites. This synaptic epitope is dependent on N-glycosylation (N-glycanase treatment reduces molecular mass and eliminates 9H6 binding), identifying a glycosylation-dependent, synapse-specific form of entactin. |
Monoclonal antibody generation, immunofluorescence, Western blot, N-glycanase treatment, N-terminal sequence analysis |
The Journal of neuroscience |
Medium |
7514212
|
| 1995 |
The mouse entactin gene spans >65 kb, contains 20 exons, and its exon organization directly corresponds to the polypeptide's structural domains (each EGF-like repeat, the thyroglobulin repeat, and each globular domain encoded by separate exons), with regional homology to the LDL receptor gene including conservation of four intron positions, indicating evolution via exon shuffling. |
Genomic cloning, restriction mapping, DNA sequencing, exon-intron boundary determination |
Genomics |
Medium |
7601446
|
| 1998 |
Human mesangial cells use both αvβ3 (via the RGD sequence in entactin's E/rod domain) and a β1-containing integrin to adhere to native entactin. Adhesion requires divalent cations. Recombinant entactin lacking the E domain RGD still supported some mesangial cell adhesion via β1 integrin, and tertiary structure of native entactin may contribute to binding properties. |
Cell adhesion assay, anti-integrin monoclonal antibody blocking, wild-type and RGD-mutant recombinant entactin fragments, metabolic labeling and immunoprecipitation |
Cell adhesion and communication |
Medium |
9686320
|
| 2000 |
Entactin-1 (nidogen-1) is exclusively produced and secreted by mesenchymal peritubular cells (not Sertoli cells) in rat testis. Anti-entactin-1 monoclonal antibodies caused loss of adhesion specifically in peritubular cells but not Sertoli cells, demonstrating an autocrine adhesion function of entactin-1 for peritubular cells. |
DD-RT-PCR, Western blot of co-cultures and monocultures, antibody perturbation assay, immunofluorescence |
European journal of cell biology |
Medium |
10727019
|
| 2001 |
Entactin significantly inhibits amyloid beta-protein (Aβ1-40) fibril formation in vitro at a 50:1 molar ratio (Aβ:entactin). The inhibitory mechanism involves entactin inducing a random coil structure in Aβ40, as shown by circular dichroism spectroscopy. |
Thioflavin T fluorometric assay, electron microscopy, circular dichroism spectroscopy |
Neuroscience letters |
Medium |
11376898
|
| 2013 |
Heterozygous mutations in NID1 cause autosomal dominant Dandy-Walker malformation with occipital cephaloceles. Structural modeling of the NID1-LAMC1 complex showed that a NID1 mutation disrupts the NID1-LAMC1 (laminin γ1) protein interaction, identifying NID1 binding to laminin as functionally critical for posterior fossa development. |
Whole-exome sequencing, protein interaction network analysis, structural modeling of NID1-LAMC1 complex |
Human mutation |
Medium |
23674478
|
| 2014 |
An 855 bp deletion in bovine NID1 spanning exon 19/intron 19 border causes skipping of exon 19, frameshifting, and premature stop (p.1164fs27X), truncating the C-terminal domain essential for binding with matrix assembly complexes. This causes autosomal recessive inherited cataract and neurological abnormalities in cattle. |
Genome-wide association study, homozygosity mapping, whole genome sequencing, RT-PCR (demonstrating exon skipping), pedigree analysis |
PloS one |
Medium |
25347398
|
| 2018 |
In C. elegans, NID-1/Nidogen localizes to all basement membranes; its localization depends on Laminin (loss of Laminin strongly reduces NID-1 BM localization). Ndg/nid-1 null mutants have ultrastructural BM defects compromising barrier function and stability. Genetic epistasis places nid-1 in the same pathway as unc-52/Perlecan and the netrin axon guidance signaling cassette for establishing correct somatosensory dendrite number; UNC-52/Perlecan is required to correctly localize NID-1. |
Genetic knockout (Ndg-null and unc-52 mutants), ultrastructural analysis (EM), barrier function assay, genetic epistasis, fluorescence localization |
Development (Cambridge, England) |
High |
29678816 30567930
|
| 2006 |
Entactin-1 overexpression in myoblasts (retroviral system) leads to higher proliferation rate and reduced expression of myogenic differentiation markers after induction, demonstrating that entactin-1 opposes myogenic differentiation. Conversely, entactin-2 is a primary response gene transiently induced during myogenesis. |
Retroviral overexpression, siRNA knockdown, RT-PCR for differentiation markers, cycloheximide and actinomycin D treatment, p38 MAPK inhibitors |
Differentiation; research in biological diversity |
Medium |
17177854
|
| 2019 |
NID1 is a downstream target of p53/miR-192/miR-215 axis in colorectal cancer cells. p53 activates miR-192 and miR-215, which directly target NID1 mRNA to repress its expression. Secreted NID1 is required and sufficient for inducing EMT, invasion, and migration in epithelial-like CRC cells via paracrine signaling. |
miRNA target prediction and validation, conditioned medium transfer, NID1 knockdown and overexpression, CRC cell migration/invasion assays, cytokine array |
Cellular and molecular gastroenterology and hepatology |
Medium |
30831320
|
| 2021 |
Nid1 is secreted by enteric neurons and elevated in the Ndrg4-/- enteric nervous system secretome. ENS-derived Nid1 (and Fibulin-2) enhances migration capacities of colorectal cancer cells and promotes organoid growth. |
Ndrg4 knockout mouse, in vitro co-culture of ENS cells and intestinal organoids, quantitative proteomics of secretome, CRC cell migration assay |
EMBO reports |
Medium |
33890711
|
| 2022 |
NID-1 is highly secreted by skeletal muscle fibro-adipogenic/mesenchymal progenitors (FAPs) during obesity. Increased muscle NID-1 impairs muscle stem cell proliferation and primes FAPs for fibrogenic differentiation leading to excessive ECM deposition. |
High fat diet mouse model, cell secretome analysis, in vitro myoblast treatment with NID-1, immunofluorescence, muscle stem cell functional assay |
Matrix biology |
Medium |
35963565
|
| 2023 |
NID1 is a direct transcriptional target of the EMT-inducing transcription factor SNAIL: ectopic SNAIL expression induces NID1, and SNAIL occupancy was detected at an E-box upstream of the NID1 transcription start site by ChIP. NID1 signals through its receptors ITGA3, ITGB1, and ITGAV; ectopic NID1 or NID1-conditioned medium conferred lung metastatic capacity to non-metastatic CRC cells in xenotransplantation. |
ChIP assay for SNAIL at NID1 E-box, ectopic expression of SNAIL and NID1, xenotransplantation lung metastasis model, bioinformatics of patient datasets, ITGAV knockdown viability assay |
Cancers |
Medium |
38001576
|
| 2023 |
COL4A1 physically binds to NID1, as confirmed by co-immunoprecipitation in OSCC cells. NID1 overexpression rescues the inhibitory effects of COL4A1 knockdown on cell proliferation, migration, invasion, and EMT, placing NID1 downstream of COL4A1. |
Co-immunoprecipitation, COL4A1 knockdown, NID1 overexpression rescue experiment, proliferation/migration/invasion assays |
Experimental and therapeutic medicine |
Medium |
37006878
|
| 2026 |
In C. elegans, NID-1 expressed by body wall muscles or hypodermis promotes local guidance of regenerating motor axons alongside neighboring neuronal processes (PVD dendrites). Loss of nid-1 disrupts axon-PVD colocalization, increases displacement from the pre-injury dorsal nerve cord contact point, and impairs synapse reformation and functional recovery. Muscle-derived NID-1 specifically is required for synapse reformation. Genetic data indicate NID-1 guides regenerating axons in coordination with laminin and integrin; ectopic integrin expression in GABAergic neurons reroutes their regenerating axons alongside PVD dendrites in a NID-1-dependent manner. |
nid-1 null mutant C. elegans, laser axotomy/axon regeneration assay, tissue-specific rescue (muscle, hypodermis, neuron), fluorescence imaging of axon guidance, synapse reformation assay, functional recovery assay, genetic epistasis with laminin and integrin |
bioRxivpreprint |
Medium |
41890084
|